162 related articles for article (PubMed ID: 35259803)
1. Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.
Mehta RM; Bansal S; Kalpakkam H
Lung India; 2022; 39(2):187-190. PubMed ID: 35259803
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
3. COVID-19-Associated Pulmonary Mucormycosis.
Krishna V; Bansal N; Morjaria J; Kaul S
J Fungi (Basel); 2022 Jul; 8(7):. PubMed ID: 35887466
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
[TBL] [Abstract][Full Text] [Related]
5. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
Muthu V; Agarwal R; Patel A; Kathirvel S; Abraham OC; Aggarwal AN; Bal A; Bhalla AS; Chhajed PN; Chaudhry D; Garg M; Guleria R; Krishnan RG; Kumar A; Maheshwari U; Mehta R; Mohan A; Nath A; Patel D; Rudramurthy SM; Saxena P; Sethuraman N; Singhal T; Soman R; Thangakunam B; Varghese GM; Chakrabarti A
Lancet Infect Dis; 2022 Sep; 22(9):e240-e253. PubMed ID: 35390293
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, predictors, and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care center in South India.
Thanjavur Sethuraman K; Athimanjeri Thiruvengadam J; Ravichandran A; Thoppappatty Sengottaiyan S
Curr Med Mycol; 2023 Sep; 9(3):33-37. PubMed ID: 38361963
[TBL] [Abstract][Full Text] [Related]
7. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis following COVID-19 infection-An epidemic developing in a pandemic, a case series from a tertiary care hospital of India.
Singhai A; Unnikrishnan S; Jain P
J Family Med Prim Care; 2022 Apr; 11(4):1568-1572. PubMed ID: 35516677
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis Epidemic in Covid Era: A Sinister Superinfection.
George SP; Bhalot L; Verma J; Godha S; Gupta Y; Mundra RK
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3501-3506. PubMed ID: 37974856
[TBL] [Abstract][Full Text] [Related]
10. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
[TBL] [Abstract][Full Text] [Related]
11. Imaging spectrum of rhino-orbital-cerebral mucormycosis secondary to COVID-19 infection: a reporting checklist.
Deshmukh YA; Vaid S; Chandorkar A; Atre A; Patil S
Pol J Radiol; 2022; 87():e333-e347. PubMed ID: 35892068
[TBL] [Abstract][Full Text] [Related]
12. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
[TBL] [Abstract][Full Text] [Related]
13. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
14. A Case of Post-COVID-19 Rhino-Cerebral Mucormycosis in an Immunocompromised Patient.
Faria L; Mahin T; Qader MA; Ahmed M; Anwar MA
Cureus; 2023 Jul; 15(7):e42652. PubMed ID: 37644947
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
16. Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India.
Nehara HR; Puri I; Singhal V; Ih S; Bishnoi BR; Sirohi P
Indian J Med Microbiol; 2021 Jul; 39(3):380-383. PubMed ID: 34052046
[TBL] [Abstract][Full Text] [Related]
17. A critical appraisal of mucormycosis in COVID- 19 patients in a tertiary care centre in India.
Raychaudhuri S; Taneja J; Sasidharan J; Pujani M; Singh K; Chatterjee T; Jain M; Chandoke R; Rai A; Abbas Z; Das A
Curr Med Mycol; 2023 Mar; 9(1):1-7. PubMed ID: 37867588
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
19. A case series of post COVID-19 mucormycosis-a neurological prospective.
Roushdy T; Hamid E
Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):100. PubMed ID: 34335016
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 associated pulmonary mucormycosis: A systematic review of published cases with review of literature.
Rai DK
J Family Med Prim Care; 2022 Apr; 11(4):1244-1249. PubMed ID: 35516689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
